RNA sequencing 012467
Ended Purchase Order Awarded Last action
- Contract number
- HHSN261201800081P
- Awardee
-
Irepertoire Inc. UEI GT35KNG2JGF4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,525
Award facts
- Contract value 100% obligated
- $6,525.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$70 | |
| Original award | $6,595 |
About this award
The National Cancer Institute awarded a purchase order to Irepertoire Inc. for $6,525.00 on December 12, 2017, for RNA sequencing services. Performance is located in Bethesda, Maryland. The order is firm-fixed-price with an ultimate completion date of December 29, 2017. Irepertoire Inc. is a small disadvantaged business providing advanced molecular biology and immunological research services, with core expertise in T-cell receptor sequencing and deep immune repertoire analysis.
Quick answers
Who was awarded contract HHSN261201800081P?
HHSN261201800081P was awarded to Irepertoire Inc. by National Cancer Institute (National Institutes of Health) on December 12, 2017.
How much is contract HHSN261201800081P worth?
The government has obligated $6,525 on HHSN261201800081P.
Was contract HHSN261201800081P competed?
The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award